View in EDS HTML Full Text PDF Full Text

Homologous recombination deficiency (HRD) tests for ovarian cancer: a multicenter French phase II study (HERO).

Saved in:
Bibliographic Details
Title: Homologous recombination deficiency (HRD) tests for ovarian cancer: a multicenter French phase II study (HERO).
Authors: Leman, Raphaël1,2 (AUTHOR) r.leman@baclesse.unicancer.fr, Cherifi, François3 (AUTHOR), Leheurteur, Marianne4 (AUTHOR), Theret, Pierrick5 (AUTHOR), Pasquesoone, Camille6 (AUTHOR), Saint-Ghislain, Mathilde6 (AUTHOR), Bresson, Lucie6 (AUTHOR), Denoyelle, Christophe7,8 (AUTHOR), Vigneron, Nicolas7,8,9 (AUTHOR), Poulain, Laurent7,8 (AUTHOR), Delepee, Raphaël7,8,10 (AUTHOR), Berby, Benoit11 (AUTHOR), Dremaux, Julie12 (AUTHOR), Dumont, Aurélie13 (AUTHOR), Blanc-Fournier, Cécile14 (AUTHOR), Jeanne, Corinne14 (AUTHOR), Briand, Mélanie7,8 (AUTHOR), Rousseau, Nathalie15 (AUTHOR), Pepin, Louis-Ferdinand16 (AUTHOR), Deruche, Elodie17 (AUTHOR)
Source: BMC Cancer. 7/1/2025, Vol. 25 Issue 1, p1-9. 9p.
Database: Academic Search Ultimate
Full text is not displayed to guests.
Description
ISSN:14712407
DOI:10.1186/s12885-025-14423-2